These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11417114)

  • 21. Use of neuraminidase inhibitors to combat pandemic influenza.
    Democratis J; Pareek M; Stephenson I
    J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuraminidase inhibitors in therapy of influenza].
    Fladerer P; Wenisch C
    Acta Med Austriaca; 2000; 27(5):133-40. PubMed ID: 11261262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of influenza with neuraminidase inhibitors: virological implications.
    Roberts NA
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1895-7. PubMed ID: 11779389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors.
    Liao LE; Kowal S; Cardenas DA; Beauchemin CAA
    PLoS One; 2017; 12(8):e0183621. PubMed ID: 28837615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zanamivir: from drug design to the clinic.
    Elliott M
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity.
    Jin J; Chen Y; Wang D; Ma L; Guo M; Zhou C; Dou J
    Arch Pharm Res; 2018 Jun; 41(6):664-676. PubMed ID: 29572682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [M2 inhibitors and neuraminidase inhibitors].
    Klebe G; Schlitzer M
    Pharm Unserer Zeit; 2011 Mar; 40(2):144-50. PubMed ID: 21630541
    [No Abstract]   [Full Text] [Related]  

  • 30. New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors.
    Oxford JS; Novelli P; Sefton A; Lambkin R
    Antivir Chem Chemother; 2002 Jul; 13(4):205-17. PubMed ID: 12495208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
    Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza.
    Khare MD; Sharland M
    Expert Opin Pharmacother; 2000 Mar; 1(3):367-75. PubMed ID: 11249523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuraminidase inhibitors for treatment of influenza A and B infections.
    MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2011 Jan; 53(1355):1-3. PubMed ID: 21212742
    [No Abstract]   [Full Text] [Related]  

  • 36. Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity.
    Laborda P; Wang SY; Voglmeir J
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27845731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel approach to antiviral therapy for influenza.
    Colman PM
    J Antimicrob Chemother; 1999 Nov; 44 Suppl B():17-22. PubMed ID: 10877458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuraminidase inhibitor].
    Kaji M
    Nihon Rinsho; 2000 Nov; 58(11):2293-8. PubMed ID: 11225320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of influenza resistance and treatment.
    Weinstock DM; Zuccotti G
    JAMA; 2009 Mar; 301(10):1066-9. PubMed ID: 19255112
    [No Abstract]   [Full Text] [Related]  

  • 40. New approaches to influenza chemotherapy. Neuraminidase inhibitors.
    Calfee DP; Hayden FG
    Drugs; 1998 Oct; 56(4):537-53. PubMed ID: 9806102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.